Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease.

Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease.

Item
http://www.wikidata.org/entity/Q34575780
(-)-Phenserine attenuates soman-induced neuropathologyCognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic MechanismsSynthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-Synuclein synthesis, interleukin-1β release, and cholNeural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α7 Nicotinic Receptor DrugsSyntheses, neural protective activities, and inhibition of glycogen synthase kinase-3β of substituted quinolines.Alcohol-Induced Molecular Dysregulation in Human Embryonic Stem Cell-Derived Neural Precursor Cells.Neural stem cells isolated from amyloid precursor protein-mutated mice for drug discoveryMulti-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy.Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke.Meserine, a novel carbamate AChE inhibitor, ameliorates scopolamine-induced dementia and alleviates amyloidogenesis of APP/PS1 transgenic mice.Proteinase-activated receptor 2 modulates corticotropin releasing hormone-induced brain-derived neurotrophic factor release from microglial cells.Repositioning drugs for traumatic brain injury - N-acetyl cysteine and PhenserineIron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases.Does traumatic brain injury hold the key to the Alzheimer's disease puzzle?Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP/PS1 mouse.
P2860

Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease.

Item
http://www.wikidata.org/entity/Q34575780
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Neurotrophic and neuroprotecti ...... drugs for Alzheimer's disease.
@ast
Neurotrophic and neuroprotecti ...... drugs for Alzheimer's disease.
@en
Neurotrophic and neuroprotecti ...... drugs for Alzheimer's disease.
@nl
type
label
Neurotrophic and neuroprotecti ...... drugs for Alzheimer's disease.
@ast
Neurotrophic and neuroprotecti ...... drugs for Alzheimer's disease.
@en
Neurotrophic and neuroprotecti ...... drugs for Alzheimer's disease.
@nl
prefLabel
Neurotrophic and neuroprotecti ...... drugs for Alzheimer's disease.
@ast
Neurotrophic and neuroprotecti ...... drugs for Alzheimer's disease.
@en
Neurotrophic and neuroprotecti ...... drugs for Alzheimer's disease.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Neurotrophic and neuroprotecti ...... drugs for Alzheimer's disease.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0054887
P407
P433
P478
P50
P577
P5875
P698
P921
P932